GILD
55
5
RF
44
10
NRG
32
5
UA
48
6
AIV
39
6
DUK
49
4
UAL
73
3
NEE
39
9
FOXA
67
5
EMN
40
5
KHC
11
2
HCA
37
7
HSIC
42
2
ITW
45
2
RCL
74
5
CPB
24
2
SCHW
40
3
UNP
38
5
STZ
42
2
PLD
35
5
GILD
55
5
RF
44
10
NRG
32
5
UA
48
6
AIV
39
6
DUK
49
4
UAL
73
3
NEE
39
9
FOXA
67
5
EMN
40
5
KHC
11
2
HCA
37
7
HSIC
42
2
ITW
45
2
RCL
74
5
CPB
24
2
SCHW
40
3
UNP
38
5
STZ
42
2
PLD
35
5
Financhill
Back

Lifecore Biomedical 10K Form

Buy
54

LFCR
Lifecore Biomedical

Last Price:
$7.01
Seasonality Move:
6.07%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive LFCR News And Ratings

See the #1 stock for the next 7 days that we like better than LFCR

LFCR Financial Statistics

Sales & Book Value

Annual Sales: $128.3M
Cash Flow: $6M
Price / Cash Flow: 0
Annual Sales: $0.37
Price / Book: 15.52

Profitability

EPS (TTM): 0.23000
Net Income (TTM): $12M
Gross Margin: $41.9M
Return on Equity: 475.5%
Return on Assets: 4.82%

Lifecore Biomedical Earnings Forecast

Key Lifecore Biomedical Financial Ratios

  • The Gross Profit Margin over the past 29 years for LFCR is 32.63%.
  • The Selling, General & Administrative Expenses for LFCR have been equal to 31.55% of Gross Profit Margin.
  • The Research & Development expenses have been 6.69% of Revenue.
  • The Interest Expense is 150.59% of Operating Income.
  • The Net Earning history of LFCR is 9.37% of Total Revenues.
  • Per Share Earnings over the last 29 years have been positive in 15 years.

Lifecore Biomedical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: LFCR
Website: lifecore.com

Debt

Debt-to-Equity Ratio: 10.72
Current Ratio: 2.08
Quick Ratio: 1.02

Price-to-Earnings

Trailing P/E Ratio: 22.59
Forward P/E Ratio: 0

LFCR Technical Analysis vs Fundamental Analysis

Buy
54
Lifecore Biomedical (LFCR) is a Buy

Is Lifecore Biomedical a Buy or a Sell?